NCT00062868
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +17 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
- The Methodist Hospital Houston, Texas, United States
Clinical trial condition
Non Hodgkin Lymphoma
Explore clinical trials studying Non Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
100 public trials
30 recruiting studies
Non Hodgkin Lymphoma trial results
NCT03619993
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
- Research Site Aschaffenburg, Germany
- Research Site Augsburg, Germany
- Research Site Berlin, Germany
- Research Site Bonn, Germany
NCT00982449
- Conditions
- DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, +37 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
Completed
PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
NCT00332202
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anchorage, Alaska, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
NCT02339805
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Centre Henri Becquerel Rouen, France
Completed
Copanlisib Pharmacodynamic Study
NCT02155582
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Bruxelles - Brussel, Belgium
- Bruxelles - Brussel, Belgium
- Ghent, Belgium
- Caen, France
Completed
Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture
NCT00808171
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Department of Pediatrics - Hematology section - Clinical Hospital of Minas Gerais Belo Horizonte, Minas Gerais, Brazil
NCT01482754
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- National University Hospital Singapore
NCT00185445
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Bologna, BO, Italy
- Cesena, FC, Italy
- Forlì, FC, Italy
- Genova, GE, Italy
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Hospital Infanta Cristina Badajoz, Badajoz_Extremadura, Spain
- Hospital del Mar Barcelona, Barcelona_ Cataluña, Spain
- Instituto Catalán de Oncología (ICO) Barcelona, Barcelona_Cataluña, Spain
- Hospital San Pedro de Alcántara Cáceres, Cáceres_Extremadura, Spain